Home/Filings/4/0001209191-22-044678
4//SEC Filing

ABBE CHARLES J 4

Accession 0001209191-22-044678

CIK 0001227025other

Filed

Aug 4, 8:00 PM ET

Accepted

Aug 5, 8:08 PM ET

Size

25.1 KB

Accession

0001209191-22-044678

Insider Transaction Report

Form 4
Period: 2022-08-03
Transactions
  • Disposition to Issuer

    Non-Qualified Stock Option (right to buy)

    2022-08-037,6410 total
    Exercise: $10.17Common Stock (7,641 underlying)
  • Disposition to Issuer

    Common Stock

    2022-08-03139,6840 total
  • Disposition to Issuer

    Non-Qualified Stock Option (right to buy)

    2022-08-038,9600 total
    Exercise: $8.56Common Stock (8,960 underlying)
  • Disposition to Issuer

    Non-Qualified Stock Option (right to buy)

    2022-08-033,0900 total
    Exercise: $8.09Common Stock (3,090 underlying)
  • Disposition to Issuer

    Non-Qualified Stock Option (right to buy)

    2022-08-032,8800 total
    Exercise: $8.68Common Stock (2,880 underlying)
  • Disposition to Issuer

    Restricted Stock Unit (right to acquire)

    2022-08-035,7870 total
    Exercise: $0.00Common Stock (5,787 underlying)
  • Disposition to Issuer

    Non-Qualified Stock Option (right to buy)

    2022-08-037,5210 total
    Exercise: $9.20Common Stock (7,521 underlying)
  • Disposition to Issuer

    Non-Qualified Stock Option (right to buy)

    2022-08-032,6560 total
    Exercise: $9.41Common Stock (2,656 underlying)
Footnotes (3)
  • [F1]Pursuant to the Agreement and Plan of Merger (the "Merger Agreement") dated November 3, 2021, by and among the Issuer, Lumentum Holdings Inc., a Delaware corporation ("Lumentum"), and Neptune Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Lumentum ("Merger Sub"), on August 3, 2022 (the "Closing Date"), Merger Sub merged with and into the Issuer (the "Merger"), with the Issuer continuing as the surviving corporation and a wholly owned subsidiary of Lumentum. In connection with the Merger, these shares were cancelled and converted into the right to receive $16.00 in cash, without interest, per share, subject to the terms and conditions of the Merger Agreement (the "Merger Consideration").
  • [F2]Options to purchase common stock of the Issuer, whether vested or unvested as of immediately prior to the Closing Date, were cancelled and converted into the right to receive the Merger Consideration, less the exercise price per share of such cancelled option.
  • [F3]Restricted Stock Unit Awards of the Issuer, whether vested or unvested as of immediately prior to the Closing Date, were cancelled and converted into the right to receive the Merger Consideration.

Issuer

NEOPHOTONICS CORP

CIK 0001227025

Entity typeother

Related Parties

1
  • filerCIK 0001037108

Filing Metadata

Form type
4
Filed
Aug 4, 8:00 PM ET
Accepted
Aug 5, 8:08 PM ET
Size
25.1 KB